Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02273375
Title Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | CAN | AUS

No variant requirements are available.